Neo-Bionica Appoints Uli Gommel As Chief Technology Officer | National News
Neo-Bionica Appoints Uli Gommel As Chief Technology Officer
Neo-Bionica, a leading innovator in medical device development and manufacturing, has announced the appointment of Uli Gommel as its new Chief Technology Officer (CTO). This strategic move solidifies Neo-Bionica’s position as a global service provider in the field of neurotechnologies and smart MedTech devices.
Revolutionizing the Field of Neurotechnology
Under Uli Gommel’s leadership, Neo-Bionica aims to revolutionize the way companies bring novel neurotechnologies and smart MedTech devices to market. Gommel’s expertise in bioengineering, fabrication, and regulatory know-how will accelerate the development of implantable and wearable bioelectronics devices.
Neo-Bionica’s Commitment to the US Market
With Uli Gommel at the helm, Neo-Bionica is poised for rapid growth in the US. Gommel’s appointment signifies the company’s dedication to serving the needs of this significant market. Neo-Bionica’s CEO, Dr. Ludovic Labat, expressed confidence in Gommel’s alignment with the company’s mission and vision.
“Not only does Uli’s expertise and vision align perfectly with our mission to help companies realize the promise of bioelectric devices, but his presence in the US also signals our commitment to serving the needs of this significant market. With his leadership, Neo-Bionica will continue to grow quickly and smartly,” said Dr. Labat.
Establishing a Permanent Foothold in the US
Neo-Bionica was established in 2021 to address the gap in the Australian market for advanced MedTech and Neurotech devices. However, the company’s expertise and services have been in high demand not only locally but also internationally. In response to this demand, Neo-Bionica expedited its plans to establish a permanent presence in the US, with Uli Gommel’s appointment playing a pivotal role in this expansion.
About Neo-Bionica:
Neo-Bionica is an advanced MedTech manufacturer specializing in commercialization and…
